X4 Pharmaceuticals
XFOR
XFOR
95 hedge funds and large institutions have $219M invested in X4 Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
70% more funds holding
Funds holding: 56 → 95 (+39)
0.7% more ownership
Funds ownership: 1.68% → 2.37% (+0.7%)
Holders
95
Holding in Top 10
2
Calls
$10.9M
Puts
$1.85M
Top Buyers
| 1 | +$17M | |
| 2 | +$8.93M | |
| 3 | +$8.48M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.3M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$7.29M |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$1.88M | |
| 3 | -$1.42M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.03M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$740K |